SCHEMBL29526451

SCHEMBL29526451

COc1cc(C(=O)O)ccc1Nc1ncc(C(N)=O)c(Nc2ccccc2C(F)(F)F)n1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 6/20 0.65
LRRK2 Q5S007 6/20 0.55
PTK2 Q05397 4/20 0.53
MAPK8 P45983 1/20 0.52
MAPK9 P45984 1/20 0.52
JAK2 O60674 2/20 0.52
TYK2 P29597 2/20 0.52
JAK3 P52333 2/20 0.52
JAK1 P23458 1/20 0.52
NTRK1 P04629 1/20 0.51
KDR P35968 1/20 0.51
PTK2B Q14289 1/20 0.51
NTRK3 Q16288 1/20 0.51
NTRK2 Q16620 1/20 0.51
CDC7 O00311 1/20 0.51
ROCK2 O75116 1/20 0.51
MAP4K4 O95819 1/20 0.51
PIM1 P11309 1/20 0.51
PRKACA P17612 1/20 0.51
CDK7 P50613 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26970232 0.89 MAP4K1 (0.66) MAP4K1PTK2MAPK8MAPK9JAK2
SCHEMBL29526485 0.89 MAP4K1 (0.66) MAP4K1PTK2MAPK8MAPK9JAK2
SCHEMBL26970264 0.86 MAP4K1 (0.70) MAP4K1LRRK2ALK
SCHEMBL29526494 0.86 MAP4K1 (0.70) MAP4K1LRRK2ALK
SCHEMBL26970189 0.83 LRRK2 (0.66) MAP4K1LRRK2
SCHEMBL30689938 0.83 LRRK2 (0.66) MAP4K1LRRK2
SCHEMBL29526244 0.83 MAP4K1 (0.59) MAP4K1PTK2MAPK8MAPK9JAK2
SCHEMBL26970215 0.83 EGFR (0.67) MAP4K1PTK2ALK
SCHEMBL29526468 0.83 EGFR (0.67) MAP4K1PTK2ALK
SCHEMBL29525948 0.81 MAP4K1 (0.60) MAP4K1PTK2JAK2TYK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240362-A1 DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITORS OF HPK1 Merck Sharp & Dohme LLC (US) 2023-09-13 EP disclosed
WO-2022098809-A1 DIAMINOPYRIMIDINE CARBOXAMIDE INHIBITORS OF HPK1 MERCK SHARP & DOHME CORP. (US) 2022-05-12 WO disclosed